The role of interferon-alpha in the treatment of chronic myeloid leukemia
- 20 August 2007
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 18 (5-6) , 459-471
- https://doi.org/10.1016/j.cytogfr.2007.06.015
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583 [see comments]Blood, 1993
- Chronic myelogenous leukemia: a concise updateBlood, 1993
- Long-Term Treatment of Chronic Myelogenous Leukemia with Different Interferons: Results from Three StudiesLeukemia & Lymphoma, 1993
- Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1991
- The Role of Interferon in Cancer Therapy: A Current PerspectiveCA: A Cancer Journal for Clinicians, 1988
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalBlood, 1985
- Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemiaBlood, 1983
- Inhibitory Effects of Human Leukocyte and Fibroblast Interferons on Normal and Chronic Myelogenous Leukemic Granulocytic Progenitor CellsOncology, 1981
- Human leukocyte interferon preparation blocks granulopoietic differentiationBlood, 1979